ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,000 | +25.0% | 191 | 0.0% | 0.00% | – |
Q4 2021 | $4,000 | +33.3% | 191 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | -40.0% | 191 | 0.0% | 0.00% | – |
Q2 2021 | $5,000 | 0.0% | 191 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | – | 191 | – | 0.00% | – |
Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2016 | $3,000 | – | 117 | +1070.0% | 0.00% | – |
Q3 2015 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |